Table 5 Comparison of adverse reactions between the two groups
From: The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy
Groups | N | Hypoglycemia | Hypotension | Dizziness | Urinary tract infection | Incidence of adverse reactions |
|---|---|---|---|---|---|---|
Control group | 60 | 2 | 2 | 0 | 3 | 13.33 |
Experimental group | 60 | 0 | 3 | 3 | 0 | 10.00 |